TY - JOUR
T1 - Obesity-Related Hypertension
T2 - Pathogenesis, Cardiovascular Risk, and Treatment: A Position Paper of The Obesity Society and the American Society of Hypertension Landsberg et al. Obesity Related Hypertension
AU - Landsberg, Lewis
AU - Aronne, Louis J.
AU - Beilin, Lawrence J.
AU - Burke, Valerie
AU - Igel, Leon I.
AU - Lloyd-Jones, Donald
AU - Sowers, James
PY - 2013/1
Y1 - 2013/1
N2 - In light of the worldwide epidemic of obesity, and in recognition of hypertension as a major factor in the cardiovascular morbidity and mortality associated with obesity, The Obesity Society and the American Society of Hypertension agreed to jointly sponsor a position paper on obesity-related hypertension to be published jointly in the journals of each society. The purpose is to inform the members of both societies, as well as practicing clinicians, with a timely review of the association between obesity and high blood pressure, the risk that this association entails, and the options for rational, evidenced-based treatment. The position paper is divided into six sections plus a summary as follows: pathophysiology, epidemiology and cardiovascular risk, the metabolic syndrome, lifestyle management in prevention and treatment, pharmacologic treatment of hypertension in the obese, and the medical and surgical treatment of obesity in obese hypertensive patients.
AB - In light of the worldwide epidemic of obesity, and in recognition of hypertension as a major factor in the cardiovascular morbidity and mortality associated with obesity, The Obesity Society and the American Society of Hypertension agreed to jointly sponsor a position paper on obesity-related hypertension to be published jointly in the journals of each society. The purpose is to inform the members of both societies, as well as practicing clinicians, with a timely review of the association between obesity and high blood pressure, the risk that this association entails, and the options for rational, evidenced-based treatment. The position paper is divided into six sections plus a summary as follows: pathophysiology, epidemiology and cardiovascular risk, the metabolic syndrome, lifestyle management in prevention and treatment, pharmacologic treatment of hypertension in the obese, and the medical and surgical treatment of obesity in obese hypertensive patients.
UR - http://www.scopus.com/inward/record.url?scp=84871938490&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84871938490&partnerID=8YFLogxK
U2 - 10.1111/jch.12049
DO - 10.1111/jch.12049
M3 - Article
C2 - 23282121
AN - SCOPUS:84871938490
SN - 1524-6175
VL - 15
SP - 14
EP - 33
JO - Journal of Clinical Hypertension
JF - Journal of Clinical Hypertension
IS - 1
ER -